Episode 444: ESMO 2025 Preview - Prostate and Renal Cancer
Silke joins us to discuss some important data being presented in prostate cancer. Brian and Tom also cover the RCC data at ESMO 2025
--------
41:58
--------
41:58
Episode 443: ESMO 2025 Bladder Cancer Preview
Tom and Brian preview the practice-changing bladder cancer data to be presented at ESMO 2025 in Berlin
--------
32:09
--------
32:09
Episode 441: The History of IO in Urothelial Cancer - Part 2
Jonathan Rosenberg returns to finish this two-part series on IO drug development in urothelial cancer
--------
33:16
--------
33:16
Episode 440: The History of IO in Urothelial Cancer - Part 1
Jonathan Rosenberg joins in this 2-part series on the history of IO-based therapy in Urothelial Cancer
--------
45:39
--------
45:39
Episode 439: Transcriptome Expression and Treatment Sensitivity in Prostate Cancer
Gert Attard joins the show to discuss his recent Cell publication looking at tumor transcriptome-wide expression classifiers in advanced prostate cancer.
Broadcasting the latest developments in GU cancer
Hosted by Brian Rini and Tom Powles
Brian Rini MD is a Professor of Cancer Research and Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center
Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London